Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
Cuende
E
E
Vesga
J C
JC
Pérez
L B
LB
Ardanaz
M T
MT
Guinea
J
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D002675:Child, Preschool; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008262:Macrophage Activation / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D013577:Syndrome; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D008775:Methylprednisolone; D008727:Methotrexate